Pfizer plots a big move (but it's not going very far)
Yes, Pfizer is moving. But not to Ireland or the UK, as it once hoped. And this has nothing to do with its tax bill.
Pfizer has notified staffers at its world headquarters in Manhattan that it wants more up-to-date digs befitting a colossus of the global pharma industry, though it didn’t use those exact words. So it’s selling its midtown skyscraper on East 42nd and Second Avenue and looking for something a bit more modern.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.